Elixir Formulary Decisions Deliver on Member Whole-Being Health

Prescription drug spend represented 13.7% of national health expenditures in 2018, totaling $500 billion, and is...

Read More

Closing One Chapter and Starting the Next: CMS' New Portal

The 2021 audit cycle is coming to a close. The Centers for Medicare and Medicaid Services (CMS) issued its last...

Read More

News on Approval of the First Interchangeable Biosimilar Insulin and More

From development of a medication for treatment-resistant HIV with a novel mechanism of action to approval of...

Read More

Changes in the Stars: The Pandemic's Impact on Star Ratings

The pandemic continues to have a profound impact on healthcare and that includes the Centers for Medicare and...

Read More

The Journey of Orphan Drugs: History, Development and Costs

Recent attention has been given to rare or orphan diseases—more specifically, to the costs associated with the drugs...

Read More

CMS is Now Requiring Drug Management Programs: What You Need to Know

America has been in the throes of an opioid epidemic since the late ‘90s, with half a million people dying of opioid...

Read More

Embattled Alzheimer's Drug Aduhelm: What You Need to Know

Alzheimer’s is a devastating and deadly disease that affects an estimated 6.5 million Americans age 65 and older, or...

Read More

Vaccination Update: What You Need to Know About Protecting Your Members This Cold and Flu Season

With kids heading back to school, the days growing shorter and the nights getting cooler, it can only mean one...

Read More

The Post-Pandemic Job Market is Changing: Can Pharmacy Benefits Help with Recruiting and Retention?

The pandemic had a dramatic impact on the American workforce with millions of workers becoming remote employees...

Read More

The Past, Present and Future of CMS Audits

On May 14, 2021, the Centers for Medicare and Medicaid Services (CMS) released the “2020 Part C and Part D Program...

Read More